Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI |
| |
Affiliation: | 1. Clinical Trials Center, Cardiovascular Research Foundation, New York, New York;2. Department of Cardiology, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York;3. Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden;4. Medical Corps, Israel Defense Forces, Tel Hashomer, Israel;5. Department of Military Medicine, Hebrew University Hadassah School of Medicine, Jerusalem, Israel;6. Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts;7. Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig, Germany;8. Division of Cardiology, Duke University Medical Center, Durham, North Carolina;9. Division of Cardiology, Tufts Medical Center, Boston, Massachusetts;10. University Heart Center Lübeck, Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine), University Hospital Schleswig-Holstein, Lübeck, Germany;11. German Center for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Lübeck, Germany;12. Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey;13. Hôpital du Sacré-Coeur de Montréal, Montréal, Québec, Canada;14. Mary Imogene Bassett Hospital, Cooperstown, New York;15. The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York |
| |
Abstract: | BackgroundSmoking is a well-established risk factor for ST-segment elevation myocardial infarction (STEMI); however, once STEMI occurs, smoking has been associated with favorable short-term outcomes, an observation termed the “smoker’s paradox.” It has been postulated that smoking might exert protective effects that could reduce infarct size, a strong independent predictor of worse outcomes after STEMI.ObjectivesThe purpose of this study was to determine the relationship among smoking, infarct size, microvascular obstruction (MVO), and adverse outcomes after STEMI.MethodsIndividual patient-data were pooled from 10 randomized trials of patients with STEMI undergoing primary percutaneous coronary intervention. Infarct size was assessed at median 4 days by either cardiac magnetic resonance imaging or technetium-99m sestamibi single-photon emission computed tomography. Multivariable analysis was used to assess the relationship between smoking, infarct size, and the 1-year rates of death or heart failure (HF) hospitalization and reinfarction.ResultsAmong 2,564 patients with STEMI, 1,093 (42.6%) were recent smokers. Smokers were 10 years younger and had fewer comorbidities. Infarct size was similar in smokers and nonsmokers (adjusted difference: 0.0%; 95% confidence interval [CI]: −3.3% to 3.3%; p = 0.99). Nor was the extent of MVO different between smokers and nonsmokers. Smokers had lower crude 1-year rates of all-cause death (1.0% vs. 2.9%; p < 0.001) and death or HF hospitalization (3.3% vs. 5.1%; p = 0.009) with similar rates of reinfarction. After adjustment for age and other risk factors, smokers had a similar 1-year risk of death (adjusted hazard ratio [adjHR]: 0.92; 95% CI: 0.46 to 1.84) and higher risks of death or HF hospitalization (adjHR: 1.49; 95% CI: 1.09 to 2.02) as well as reinfarction (adjHR: 1.97; 95% CI: 1.17 to 3.33).ConclusionsIn the present large-scale individual patient-data pooled analysis, recent smoking was unrelated to infarct size or MVO, but was associated with a worse prognosis after primary PCI in STEMI. The smoker’s paradox may be explained by the younger age and fewer cardiovascular risk factors in smokers compared with nonsmokers. |
| |
Keywords: | infarct size percutaneous coronary intervention (PCI) smoking ST-segment elevation myocardial infarction (STEMI) CMR" },{" #name" :" keyword" ," $" :{" id" :" kwrd0035" }," $$" :[{" #name" :" text" ," _" :" cardiac magnetic resonance HF" },{" #name" :" keyword" ," $" :{" id" :" kwrd0045" }," $$" :[{" #name" :" text" ," _" :" heart failure LAD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0055" }," $$" :[{" #name" :" text" ," _" :" left anterior descending coronary artery LVEF" },{" #name" :" keyword" ," $" :{" id" :" kwrd0065" }," $$" :[{" #name" :" text" ," _" :" left ventricular ejection fraction MVO" },{" #name" :" keyword" ," $" :{" id" :" kwrd0075" }," $$" :[{" #name" :" text" ," _" :" microvascular obstruction PCI" },{" #name" :" keyword" ," $" :{" id" :" kwrd0085" }," $$" :[{" #name" :" text" ," _" :" percutaneous coronary intervention STEMI" },{" #name" :" keyword" ," $" :{" id" :" kwrd0095" }," $$" :[{" #name" :" text" ," _" :" ST-segment elevation myocardial infarction TIMI" },{" #name" :" keyword" ," $" :{" id" :" kwrd0105" }," $$" :[{" #name" :" text" ," _" :" Thrombolysis In Myocardial Infarction |
本文献已被 ScienceDirect 等数据库收录! |
|